Abstracts tagged "fibromyalgia"

Abstract Number: 2064 • 2014 ACR/ARHP Annual Meeting
Assessment of the Spanish Version of the American College Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia
B Casanueva¹, F Garcia-Fructuoso², R Belenguer³, C Alegre⁴, R López-Mejías⁵, F Genre⁵, J.V. Moreno⁶, J.L. Hernandez⁷ and MA González-Gay⁵, ¹Rheumatologist. Rheumatology Service at the Specialist Clinic of Cantabria, Santander, Spain, ²Rheumatologist. CIMA Hospital, Barcelona, Spain, ³Rheumatologist. 12 de Octubre Hospital., Valencia, Spain, ⁴Rheumatology, Hospital Universitari Vall d'Hebron, Barcelona, Spain, ⁵Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, ⁶Rheumatologist. Vall D’Hebron Hospital, Barcelona, Spain, ⁷Internist. Marqués de Valdecilla Hospital. IDIVAL., Santander, Spain
Background/Purpose: Fibromyalgia (FM) requires an expert clinical examination that impedes an easy assessment of diagnostic criteria of American College Rheumatology (ACR) 1990 in some health…
Abstract Number: 1100 • 2014 ACR/ARHP Annual Meeting
System Review: The Most Common Symptoms of Fibromyalgia Patients Other Than Pain, Fatigue, Insomnia, and Cognitive Dysfunction
Robert S. Katz¹ and Jessica L. Polyak², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients are somatically sensitive. The frequently complain of symptoms other than the core ones used for the diagnosis- pain, fatigue, poor sleep and…
Abstract Number: 2063 • 2014 ACR/ARHP Annual Meeting
Analysis of the Fibromyalgia Rapid Screening Tool Spanish Version to Detect Fibromyalgia in Primary Health Care Centers
B Casanueva¹, R Belenguer², Jv Moreno³, J Urtiaga⁴, B Urtiaga⁵, F Genre⁶, R López-Mejías⁶, Jl Hernandez⁷ and MA González-Gay⁶, ¹Rheumatologist. Rheumatology Service at the Specialist Clinic of Cantabria, Santander, Spain, ²Rheumatologist. 12 de Octubre Hospital., Valencia, Spain, ³Rheumatologist. Vall D’Hebron Hospital, Barcelona, Spain, ⁴Professor of French., Madrid, Spain, ⁵Professor of Spanish language and Literature, Madrid, Spain, ⁶Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IDIVAL, Santander, Spain, ⁷Internist. Marqués de Valdecilla Hospital. IDIVAL, Santander, Spain
Background/Purpose: The Fibromyalgia Rapid Screening Tool (FiRST) is a brief, simple and straightforward self-administered questionnaire with excellent discriminative value, of potential value for the detection…
Abstract Number: 1096 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Patients Who Have More Symptoms at Their Initial Office Visit Tend to Have a Worse Clinical Course
Robert S. Katz¹, Ben J. Small², Alexandra Small³ and Hannah Bond⁴, ¹Rush Medical College, Chicago, IL, ²MacNeal Hospital, Berwyn, IL, ³University of Illinois College of Medicine, Chicago, IL, ⁴Rheumatology Associates, Chicago, IL
Background/Purpose: Patients with the fibromyalgia syndrome (FMS) experience pain, insomnia, fatigue, and memory/concentration problems. But some fibromyalgia patients also have many additional somatic symptoms. We…
Abstract Number: 2061 • 2014 ACR/ARHP Annual Meeting
Unexpectedly High Prevalence of Immunoglobulin Deficiency in Fibromyalgia
Xavier Caro and Earl Winter, Fibromyalgia Research and Treatment Center, Northridge, CA
Background/Purpose: It has recently been shown that Fibromyalgia (FM) is commonly associated with clinical evidence of neuropathic pain language, laboratory evidence of small fiber…
Abstract Number: 1095 • 2014 ACR/ARHP Annual Meeting
Treatment of Fibromyalgia with Neurostimulation: A Randomized, Double-Blinded, Sham-Controlled Trial
R Michael Gendreau^1,2, Donald Deering³, Judith Gendreau¹ and Jeffrey Hargrove⁴, ¹Gendreau Consulting, LLC, Poway, CA, ²Cerephex Corporation, Los Altos, CA, ³St. Joseph Mercy Oakland, Pontiac, MI, ⁴Research & Development, Cerephex Corporation, Los Altos, CA
Background/Purpose: NeuroPoint is a medical device designed to provide noninvasive brain stimulation using a proprietary approach to deliver very low energy levels to deep brain…
Abstract Number: 2059 • 2014 ACR/ARHP Annual Meeting
Muscle Tension Is Increased in Fibromyalgia
Robert S. Katz¹ and Kerri Swiatnicki², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia patients have and widespread pain and tender muscles. Muscle tenderness was part of the older ACR criteria for the diagnosis of fibromyalgia. We…
Abstract Number: 1094 • 2014 ACR/ARHP Annual Meeting
Work Productivity and Healthcare Utilization in Patients with Fibromyalgia and Comorbid Depression Taking Antidepressant Medication
Jaren Landen¹, Claire Burbridge², Elizabeth Masters³, Pritha Bhadra Brown⁴, Joseph Scavone¹, Birol Emir⁴, Richard Vissing⁵, Andrew Clair⁴ and Lynne Pauer⁶, ¹Pfizer Inc, Groton, CT, ²Pfizer Ltd, Walton Oaks, United Kingdom, ³Health Economics and Outcomes Research, Pfizer Inc, New York, NY, ⁴Pfizer Inc, New York, NY, ⁵Pfizer Inc, Louisville, KY, ⁶445 Eastern Point Road, Pfizer Inc, Groton, CT
Background/Purpose Patients with fibromyalgia (FM) experience pain, sleep disruption, fatigue, and other symptoms that limit activity, impacting work productivity and increasing healthcare utilization. Here, we…
Abstract Number: 2056 • 2014 ACR/ARHP Annual Meeting
Fibromyalgia Symptoms Beyond the Pain and Its Impact on the Patient
Abdelmoneim Helal¹, Dia MF Mohasseb², Noha AH El-Sawy² and Yousra H. Abdel-Fattah³, ¹Physical Medicine, Rheumatology & rehabilitation, Professor, Alexandria, Egypt, ²Physical Medicine, Rheumatology and Rehabilitation, Professor, Alexandria, Egypt, ³Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, University of Alexandria, Alexandria, Egypt
Background/Purpose: Fibromyalgia (FM) has been promoted as the commonest cause of chronic, widespread non-articular musculoskeletal pain, stiffness and fatigue. Although pain is the central feature…
Abstract Number: 894 • 2014 ACR/ARHP Annual Meeting
Small Fiber Neuropathy in Women with Fibromyalgia. a Clinical-Pathological Correlation Using Confocal Corneal Biomicroscopy
Manuel Ramírez-Fernández¹, Laura-Aline Martinez-Martinez², Angelica Vargas-Guerrero³, Manuel Martínez-Lavín⁴, Everardo Hernandez Quintela¹ and Jorge Velazco-Caspia¹, ¹Asociación para Evitar la Ceguera en México, Mexico City, Mexico, ²Instituto Nacional de Cardiologia, Mexico City, Mexico, ³Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico, ⁴Chief Rheumatology, Instituto Nacional de Cardiologia, Mexico City, Mexico
Background/Purpose: A consistent line of investigation proposes that fibromyalgia is a sympathetically maintained neuropathic pain syndrome (Semin Arthritis Rheum 2000;29:197). This view has been recently reinforced…
Abstract Number: 2055 • 2014 ACR/ARHP Annual Meeting
Are There Immunological Abnormalities in Fibromyalgia Patients: Flow Cytometry Analysis
Robert S. Katz¹, Hannah Bond² and Daniel Pickrell², ¹Rush Medical College, Chicago, IL, ²Rheumatology Associates, Chicago, IL
Background/Purpose: Fibromyalgia is not thought to have an immunological pathogenesis: However, few studies have been done to evaluate immunological abnormalities. We analyzed lymphocyte subsets in…
Abstract Number: 401 • 2014 ACR/ARHP Annual Meeting
Association of Anti-Thyroid Autoantibodies with Fibromyalgia in Rheumatoid Arthritis
Jowairiyya Ahmad¹, Helena Blumen², Claudene George³, Asha Shrestha⁴ and Clement Tagoe⁵, ¹Geriatrics, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ²Geriatrics, Albert Einstein College of Medicine, Bronx, NY, ³Geriatrics, Albert Einstein College of Medicine/Montefiore Medical centre, Bronx, NY, ⁴Rheumatology, Albert Einstein College of Medicine/Montefiore Medical Centre, Bronx, NY, ⁵Rheumatology, Albert Einsetin College of Medicine/Montefiore Medical Centre, Bronx, NY
Background/Purpose Autoimmune thyroiditis has been linked independently with fibromyalgia and chronic widespread pain. We studied how the presence of autoimmune thyroiditis affects the clinical presentation…
Abstract Number: 1879 • 2014 ACR/ARHP Annual Meeting
The Efficacy of Pregabalin for Treating Fibromyalgia Patients with Moderate or Severe Baseline Widespread Pain
Andrew Clair and Birol Emir, Pfizer Inc, New York, NY
Background/Purpose: Pregabalin has demonstrated efficacy for the treatment of fibromyalgia (FM), but insufficient evidence exists on how the efficacy of pregabalin may differ by baseline…
Abstract Number: 252 • 2014 ACR/ARHP Annual Meeting
Preliminary Validation of the Michigan Body Map
Chad M. Brummett¹, Jenna Goesling², Rishi Bakshi³, Jennifer Wolfe⁴, Stephanie Moser⁵, David A. Williams⁶ and Afton L. Hassett⁷, ¹Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, ²Department of Anesthesiology, University of Michigan Health System, Ann Arbor, MI, ³Physical Medicine and Rehabilitation, University of Michigan Medical School, Ann Arbor, MI, ⁴Anesthesiology, University of Michigan Health System, Ann Arbor, MI, ⁵Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, ⁶Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, ⁷Anesthesiology, University of Michigan, Ann Arbor, MI
Background/Purpose One of the hallmark features of fibromyalgia and other centralized pain states is widespread body pain. We developed the Michigan Body Map (MBM) to…
Abstract Number: 1869 • 2014 ACR/ARHP Annual Meeting
Child Pain, Function, and Psychological Outcomes in an Intensive Interdisciplinary Pediatric Pain Rehabilitation Program
Cara Hoffart¹, Rawni Anderson², Amy Chapman³, Brandi Dorton³, Danielle Feltrop³, Misty Wilson³ and Dustin Wallace⁴, ¹Rheumatology and Integrative Pain Management, Children's Mercy Hospital, Kansas City, MO, ²Medical Research, Children's Mercy Hospital, Kansas City, MO, ³Children's Mercy Hospital, Kansas City, MO, ⁴Integrative Pain Management and Developmental and Behavioral, Children's Mercy Hospital, Kansas City, MO
Background/Purpose: We examined the functional, psychological, and pain-related outcomes among children with chronic pain completing an intensive interdisciplinary pediatric pain rehabilitation program. We hypothesized that…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.